Sponsors

Introducing Revvity - a scientific solutions company powering innovation

Revvity has been officially launched as a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere. The company was previously affiliated with PerkinElmer.

Born from two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity delivers end-to-end expertise and solutions from research discovery to development, and diagnosis to cure.

“The unveiling of Revvity is the capstone of a nearly year-long journey that has transformed who we are and reinforces why our work matters,” said Prahlad Singh, President and CEO of Revvity. “At Revvity, we are united with our customers to impact health across the lifespan. Our purpose is to expand the boundaries of human potential through science. We view the challenges facing our customers as a call to action.”

Revvity provides reagents, consumables, assays, instruments and software to customers in markets ranging from pharma and biotech, diagnostic laboratories, academia and government agencies. “We’re a translational company in the sense that our capabilities facilitate decision making between research and clinical customers,” remarked Singh. “With cross-business collaborations between our automation, multi-omics offerings, and our Signals software business, we have unique capabilities which put us in an optimal position to accelerate breakthrough solutions – starting with preclinical research and scientific discovery, all the way through to diagnosing and helping to treat disease.”

  • Industry leading franchises, BioLegend, EUROIMMUN, Tulip Diagnostics and ViaCord retain their own names as unique product lines.
  • The company’s comprehensive scientific software platform, previously known as PerkinElmer Informatics, will become Revvity Signals Software
  • Revvity Omics replaces PerkinElmer Genomics as the company's genomics services business.
  • Cisbio, Horizon Discovery, Nexcelom Bioscience, Omni International, Oxford Immunotec, SIRION Biotech and SonoVol will now identify as Revvity, while maintaining their specific product names.

Roadshows intended for existing and prospective customers will be scheduled in select global markets to introduce the new brand and latest innovations. Follow Revvity’s social media channels for updates. Visit the ‘Our Story’ page on the company’s website for more on Revvity’s evolution.

 

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025